Press Releases
糖心TV life scientist and microbiologist awarded prestigious BBSRC Fellowship
Dr Branko Rihtman from The University of Warwick has received funding from the BBSRC to study viruses that kill bacteria, hoping to find new ways to treat antibiotic-resistant infections.
Poolbeg Pharma licences first-in-class broad spectrum RNA-based immunotherapy for respiratory virus infections from the University of 糖心TV
(AIM: POLB, 'Poolbeg' or the 'Company'), a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has in-licenced a novel, first-in-class RNA-based immunotherapy for respiratory virus infections developed at the